People: NewLink Genetics Corp (NLNK.OQ)
25 May 2018
Mr. John B. Henneman III., is the Chief Financial Officer, Executive Vice President of Newlink Genetics Corporation. Prior to joining the Company, Mr. Henneman served for sixteen years at Integra Life Sciences (“Integra”). He joined Integra in 1998 as General Counsel and Chief Administrative Officer, was appointed Acting Chief Financial Officer in 2007, and assumed that role permanently in 2008. As Chief Financial Officer, he transformed the finance function to accommodate Integra's growth, recruited and developed key leaders in accounting, tax, financial planning and analysis and treasury, and raised almost $1 billion in new debt and equity capital. In April 2014, he was named as Corporate Vice President and Chief Administrative Officer, concurrently with the appointment of a new Chief Financial Officer. During his 16 years at Integra, in addition to his responsibilities as Chief Financial Officer, he led Integra’s business development function, playing a key role in more than 40 acquisitions and alliances, and was responsible at various times for the Company's regulatory affairs, quality systems, clinical affairs, human resources and management of Integra’s surgical instruments business. Integra is not a parent, subsidiary or other affiliate of the Company.
|Total Annual Compensation, USD||3,080,970|
|Restricted Stock Awards, USD||936,108|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||--|
|Fiscal Year Total, USD||4,017,080|